ArticleFrontiers in veterinary science2026
Biphasic tissue expression of cfa-miR-409-3p and cfa-miR-4270 during malignant transformation in canine mammary tumors: an exploratory study.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Canine mammary tumors (CMTs) are the most common malignancy in intact female dogs and represent a well-established spontaneous model for human breast cancer. MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression critically involved in carcinogenesis and are candidate non-invasive biomarkers for tumor diagnosis and prognosis. Methods: This exploratory study evaluated the tissue and plasma expression of five candidate miRNAs-cfa-miR-133a, cfa-miR-127-3p, cfa-miR-652, cfa-miR-409-3p, and cfa-miR-4270-in two independent cohorts. The tissue cohort comprised 57 mammary samples (33 carcinomas, 14 adenomas, and 10 normal tissues) analyzed by poly(A) tailing-based SYBR Green RT-qPCR. The plasma cohort included 75 dogs with mammary carcinomas and 5 healthy controls, quantified by TaqMan Advanced miRNA Assays. Results: Tissue analysis revealed that cfa-miR-133a was significantly downregulated in both adenomas and carcinomas relative to normal tissue ( Discussion: These findings indicate that tissue-level miRNA dysregulation in CMTs follows biologically coherent, progression-associated patterns aligned with the roles of human orthologs in breast cancer, whereas no significant circulating signatures were detected in plasma; however, the plasma analyses were limited by a small control group and were underpowered, and these negative findings should not be interpreted as evidence against biological relevance. These results support the design of larger, prospectively standardized investigations to validate tissue miRNA biomarkers and advance liquid biopsy approaches in canine mammary oncology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.